{"id":"NCT00325780","sponsor":"Kowa Research Europe","briefTitle":"Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia","officialTitle":"Open-Label, Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07","primaryCompletion":"2007-11","completion":"2007-11","firstPosted":"2006-05-15","resultsPosted":"2010-01-18","lastUpdate":"2010-02-02"},"enrollment":1355,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia","Dyslipidemia"],"interventions":[{"type":"DRUG","name":"Pitavastatin","otherNames":[]}],"arms":[{"label":"Pitavastatin 4 mg QD","type":"EXPERIMENTAL"}],"summary":"This study is a long-term follow-up protocol for patients who participated in study NK-104-3.01EU or study NK-104-3.02EU.","primaryOutcome":{"measure":"Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C)","timeFrame":"Baseline to 52 Weeks","effectByArm":[{"arm":"Pitavastatin 4 mg QD","deltaMin":-42.89,"sd":16.001}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":186,"countries":["Denmark","Finland","Germany","India","Israel","Italy","Netherlands","Norway","Poland","Russia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["20080236"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":49,"n":1353},"commonTop":["Blood creatine phosphokinase increased","Nasopharyngitis","Myalgia","Arthralgia","Influenza"]}}